Literature DB >> 16873766

PHOX2B mutation-confirmed congenital central hypoventilation syndrome: presentation in adulthood.

Nick A Antic1, Beth A Malow, Neale Lange, R Doug McEvoy, Amy L Olson, Peter Turkington, Wolfram Windisch, Martin Samuels, Cathy A Stevens, Elizabeth M Berry-Kravis, Debra E Weese-Mayer.   

Abstract

Congenital central hypoventilation syndrome (CCHS) typically presents in the newborn period. A case series of five adults is presented, each heterozygous for a documented polyalanine expansion mutation in the PHOX2B gene and evidence of nocturnal alveolar hypoventilation. All cases had symptoms in childhood, but survived to adulthood without ventilatory support. After identification of physiologic compromise, artificial ventilation was initiated. These adults have the mildest of the CCHS-related PHOX2B polyalanine expansion mutations, coding for only five extra alanines; three of the adults have affected offspring. Report of these cases should lead to a more rapid identification of CCHS presenting in adulthood.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16873766     DOI: 10.1164/rccm.200605-607CR

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  33 in total

1.  Late-onset, insidious course and invasive treatment of congenital central hypoventilation syndrome in a case with the Phox2B mutation: case report.

Authors:  Lia Rita Azeredo Bittencourt; Mario Pedrazzoli; Fabiana Yagihara; Gabriela Pontes Luz; Silvério Garbuio; Gustavo Antonio Moreira; João Aléssio J Perfeito; Sergio Tufik
Journal:  Sleep Breath       Date:  2011-11-19       Impact factor: 2.816

2.  Congenital central hypoventilation syndrome due to PHOX2B mutation in a Saudi child: a case report.

Authors:  Muslim Mohammed Al Saadi
Journal:  Sleep Breath       Date:  2010-11-19       Impact factor: 2.816

Review 3.  What is central sleep apnea?

Authors:  Atul Malhotra; Robert L Owens
Journal:  Respir Care       Date:  2010-09       Impact factor: 2.258

4.  Congenital central hypoventilation syndrome: four families.

Authors:  Amit Trivedi; Karen Waters; Sadasivam Suresh; Rashmi Nair
Journal:  Sleep Breath       Date:  2010-11-14       Impact factor: 2.816

5.  PHYSIOLOGY. Regulation of breathing by CO₂ requires the proton-activated receptor GPR4 in retrotrapezoid nucleus neurons.

Authors:  Natasha N Kumar; Ana Velic; Jorge Soliz; Yingtang Shi; Keyong Li; Sheng Wang; Janelle L Weaver; Josh Sen; Stephen B G Abbott; Roman M Lazarenko; Marie-Gabrielle Ludwig; Edward Perez-Reyes; Nilufar Mohebbi; Carla Bettoni; Max Gassmann; Thomas Suply; Klaus Seuwen; Patrice G Guyenet; Carsten A Wagner; Douglas A Bayliss
Journal:  Science       Date:  2015-06-11       Impact factor: 47.728

6.  Severe Positional Central Sleep Apnea in an Asymptomatic Adult With a PHOX2B Frameshift Mutation.

Authors:  Hennie C J P Janssen; Anneke T Vulto-van Silfhout; Marjolijn C J Jongmans; Annemieke H van der Hout; Sebastiaan Overeem
Journal:  J Clin Sleep Med       Date:  2018-08-15       Impact factor: 4.062

7.  Congenital central hypoventilation syndrome with PHOX2B gene mutation: are we missing the diagnosis?

Authors:  Nilay Nirupam; Rajni Sharma; Viswas Chhapola; Sandeep Kumar Kanwal; Elizabeth M Berry-Kravis; Virendra Kumar
Journal:  Indian J Pediatr       Date:  2012-07-25       Impact factor: 1.967

Review 8.  Pathophysiology of sleep apnea.

Authors:  Jerome A Dempsey; Sigrid C Veasey; Barbara J Morgan; Christopher P O'Donnell
Journal:  Physiol Rev       Date:  2010-01       Impact factor: 37.312

9.  Adult cases of late-onset congenital central hypoventilation syndrome and paired-like homeobox 2B-mutation carriers: an additional case report and pooled analysis.

Authors:  Aoi Hino; Jiro Terada; Hajime Kasai; Hikaru Shojima; Keiko Ohgino; Ayako Sasaki; Kiyoshi Hayasaka; Koichiro Tatsumi
Journal:  J Clin Sleep Med       Date:  2020-11-15       Impact factor: 4.062

Review 10.  Congenital central hypoventilation syndrome: a bedside-to-bench success story for advancing early diagnosis and treatment and improved survival and quality of life.

Authors:  Debra E Weese-Mayer; Casey M Rand; Amy Zhou; Michael S Carroll; Carl E Hunt
Journal:  Pediatr Res       Date:  2016-09-27       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.